iopromide has been researched along with Neuroendocrine Tumors in 7 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, C | 1 |
| Byun, JH | 2 |
| Hong, SM | 2 |
| An, S | 1 |
| Kim, JH | 2 |
| Lee, SS | 1 |
| Kim, HJ | 2 |
| Grazzini, G | 1 |
| Danti, G | 1 |
| Cozzi, D | 1 |
| Lanzetta, MM | 1 |
| Addeo, G | 1 |
| Falchini, M | 1 |
| Masserelli, A | 1 |
| Pradella, S | 1 |
| Miele, V | 1 |
| Foti, G | 1 |
| Boninsegna, L | 1 |
| Falconi, M | 1 |
| Mucelli, RP | 1 |
| Hong, N | 1 |
| Kim, SY | 1 |
| Kim, KW | 1 |
| Veit-Haibach, P | 1 |
| Schiesser, M | 1 |
| Soyka, J | 1 |
| Strobel, K | 1 |
| Schaefer, NG | 1 |
| Hesselmann, R | 1 |
| Clavien, PA | 1 |
| Hany, TF | 1 |
| Böhm, I | 1 |
| Pfützner, W | 1 |
| Klose, KJ | 1 |
| Li, H | 1 |
| Wang, DL | 1 |
| Liu, XW | 1 |
| Geng, ZJ | 1 |
| Xie, CM | 1 |
7 other studies available for iopromide and Neuroendocrine Tumors
| Article | Year |
|---|---|
A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis.
Topics: Contrast Media; Female; Fibrosis; Humans; Iohexol; Male; Middle Aged; Neoplasm Grading; Neuroendocri | 2017 |
Diagnostic imaging of gastrointestinal neuroendocrine tumours (GI-NETs): relationship between MDCT features and 2010 WHO classification.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Gastrointestinal Neoplasms; Humans; Iohexol; | 2019 |
Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI.
Topics: Adult; Aged; Contrast Media; Female; Humans; Iohexol; Magnetic Resonance Imaging; Male; Middle Aged; | 2013 |
Neuroendocrine neoplasms of the extrahepatic bile duct: radiologic and clinical characteristics.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Contrast Media; Female; Humans; Image En | 2015 |
Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Dihydroxyphenylalanine; Female; Humans; | 2011 |
[Individual management permits contrast media enhanced CT examination without premedication ].
Topics: Aged; Contrast Media; Drug Eruptions; Female; Humans; Intradermal Tests; Iohexol; Iopamidol; Neuroen | 2012 |
Computed tomography characterization of neuroendocrine tumors of the thymus can aid identification and treatment.
Topics: Adult; Biopsy, Large-Core Needle; Contrast Media; Female; Humans; Iohexol; Lymphatic Metastasis; Mal | 2013 |